These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25622654)

  • 21. Effective and specific inhibition of the CD40-CD154 costimulatory interaction by a naphthalenesulphonic acid derivative.
    Margolles-Clark E; Kenyon NS; Ricordi C; Buchwald P
    Chem Biol Drug Des; 2010 Oct; 76(4):305-13. PubMed ID: 20636329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and analyses of natural compounds as potential inhibitors of TRAF6-Basigin interactions in melanoma using structure-based virtual screening and molecular dynamics simulations.
    Biswas R; Chowdhury N; Mukherjee R; Bagchi A
    J Mol Graph Model; 2018 Oct; 85():281-293. PubMed ID: 30253283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
    Chen H; Li M; Campbell RA; Burkhardt K; Zhu D; Li SG; Lee HJ; Wang C; Zeng Z; Gordon MS; Bonavida B; Berenson JR
    Oncogene; 2006 Oct; 25(49):6520-7. PubMed ID: 16702955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct contributions of different CD40 TRAF binding sites to CD154-induced dendritic cell maturation and IL-12 secretion.
    Mackey MF; Wang Z; Eichelberg K; Germain RN
    Eur J Immunol; 2003 Mar; 33(3):779-89. PubMed ID: 12616498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organic dyes as small molecule protein-protein interaction inhibitors for the CD40-CD154 costimulatory interaction.
    Buchwald P; Margolles-Clark E; Kenyon NS; Ricordi C
    J Mol Recognit; 2010; 23(1):65-73. PubMed ID: 19621420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-inflammatory effects of benzenediamine derivate FC-98 on sepsis injury in mice via suppression of JNK, NF-κB and IRF3 signaling pathways.
    Song Y; Liu X; Yue H; Ji J; Dou H; Hou Y
    Mol Immunol; 2015 Oct; 67(2 Pt B):183-92. PubMed ID: 26032013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α.
    Singh K; Munuganti RS; Leblanc E; Lin YL; Leung E; Lallous N; Butler M; Cherkasov A; Rennie PS
    Breast Cancer Res; 2015 Feb; 17(1):27. PubMed ID: 25848700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel benzenediamine derivate rescued mice from experimental sepsis by attenuating proinflammatory mediators via IRAK4.
    Dou H; Song Y; Liu X; Yang L; Jiang N; Chen D; Li E; Tan R; Hou Y
    Am J Respir Cell Mol Biol; 2014 Aug; 51(2):191-200. PubMed ID: 24588661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of new Fyn kinase inhibitors using a FLAP-based approach.
    Poli G; Tuccinardi T; Rizzolio F; Caligiuri I; Botta L; Granchi C; Ortore G; Minutolo F; Schenone S; Martinelli A
    J Chem Inf Model; 2013 Oct; 53(10):2538-47. PubMed ID: 24001328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuning of CD40-CD154 interactions in human B-lymphocyte activation: a broad array of in vitro models for a complex in vivo situation.
    Néron S; Nadeau PJ; Darveau A; Leblanc JF
    Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):25-40. PubMed ID: 21234809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacophore based virtual screening, molecular docking studies to design potent heat shock protein 90 inhibitors.
    Sakkiah S; Thangapandian S; John S; Lee KW
    Eur J Med Chem; 2011 Jul; 46(7):2937-47. PubMed ID: 21531051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of terminal differentiation of B cells mediated by CD27 and CD40 involves signaling through JNK.
    Satpathy S; Shenoy GN; Kaw S; Vaidya T; Bal V; Rath S; George A
    J Immunol; 2010 Dec; 185(11):6499-507. PubMed ID: 20974987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
    Zhang X; Wong SE; Lightstone FC
    J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD40/CD40L interaction induces Abeta production and increases gamma-secretase activity independently of tumor necrosis factor receptor associated factor (TRAF) signaling.
    Volmar CH; Ait-Ghezala G; Frieling J; Weeks OI; Mullan MJ
    Exp Cell Res; 2009 Aug; 315(13):2265-74. PubMed ID: 19422822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory pathway network-based drug repositioning and molecular phenomics.
    Gu J; Crosier PS; Hall CJ; Chen L; Xu X
    Mol Biosyst; 2016 Aug; 12(9):2777-84. PubMed ID: 27345454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo.
    Martínez de Lizarrondo S; Roncal C; Calvayrac O; Rodríguez C; Varo N; Purroy A; Lorente L; Rodríguez JA; Doeuvre L; Hervás-Stubbs S; Angles-Cano E; Páramo JA; Martínez-González J; Orbe J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1477-87. PubMed ID: 22492089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of CD40 endogenous S-nitrosylation during inflammatory response in endotoxemic mice and patients with sepsis.
    Godoy LC; Moretti AI; Jurado MC; Oxer D; Janiszewski M; Ckless K; Velasco IT; Laurindo FR; Souza HP
    Shock; 2010 Jun; 33(6):626-33. PubMed ID: 20473113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening.
    Mouhsine H; Guillemain H; Moreau G; Fourati N; Zerrouki C; Baron B; Desallais L; Gizzi P; Ben Nasr N; Perrier J; Ratsimandresy R; Spadoni JL; Do H; England P; Montes M; Zagury JF
    Sci Rep; 2017 Jun; 7(1):3424. PubMed ID: 28611375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico investigation of potential TRAF6 inhibitor from traditional Chinese medicine against cancers.
    Chen KC; Lee WY; Chen HY; Chen CY
    Biomed Res Int; 2014; 2014():429486. PubMed ID: 25089269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Silico Identification and Evaluation of Natural Products as Potential Tumor Necrosis Factor Function Inhibitors Using Advanced Enalos Asclepios KNIME Nodes.
    Papadopoulou D; Drakopoulos A; Lagarias P; Melagraki G; Kollias G; Afantitis A
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.